Merck partners with Cerevance on Alzheimer’s research initiative
The pharmaceutical company has inked a strategic collaboration with the drug discovery firm, centering on uncovering novel targets in Alzheimer’s disease.
Archives for August 11, 2022
Sanofi predicts pivot to high-value flu vaccines will drive another year of record sales
Sanofi expects to post another year of record influenza vaccine sales as it reaps the benefits of shifting its focus to higher-value products.
Novartis tips Lucentis to weather the arrival of biosimilar copies in Europe
Novartis has set out how it expects biosimilars to affect its business in the coming years, identifying sales of $80bn that are open to its off-patent business and expressing confidence in the ability of some of its own products to weather the arrival of...
Charles River Laboratories becomes first CDMO in North America to receive EMA approval for commercial production of allogenic cell therapy drug product
Charles River Laboratories, International Inc. has received regulatory approval - in the form of Good Manufacturing Practice (GMP) certification - to commercially produce allogeneic cell therapy drug products for distribution in Europe, from the European...